Tetanus toxoid
Highest phase reached
Approved
Drug type
Vaccine component
First approval year
1996
- First approval year
- 1996
- Listing at source
- Listed
- Highest phase reached
- Approved
- Drug type
- Vaccine component
- Drug name
- Tetanus toxoid
- equilis te
- Equilis te
- tetanus toxoid component of hexacima
- Tetanus toxoid component of hexacima
- tetanus toxoid component of hexavac
- Tetanus toxoid component of hexavac
- tetanus toxoid component of hexyon
- Tetanus toxoid component of hexyon
- tetanus toxoid component of infanrix hepb
- Tetanus toxoid component of infanrix hepb
- tetanus toxoid component of infanrix hexa
- Tetanus toxoid component of infanrix hexa
- tetanus toxoid component of infanrix penta
- Tetanus toxoid component of infanrix penta
- tetanus toxoid component of primavax
- Tetanus toxoid component of primavax
- tetanus toxoid component of quintanrix
- Tetanus toxoid component of quintanrix
- tetanus toxoid component of triacelluvax
- Tetanus toxoid component of triacelluvax
- tetanus toxoid component of tritanrix hepb
- Tetanus toxoid component of tritanrix hepb
- tetanus toxoid component of vaxelis
- Tetanus toxoid component of vaxelis
- Td (tetanus toxoid)
- td tetanus toxoid
- tetanus toxoid
- Tetanus toxoid
- Tetanus Toxoid
- ChEMBL ID
- CHEMBL2108875
- RxNorm IDs (RxCUI)
- 798306
- J07AM01
- J07AM51
- J07AM52
Sources for recorded values
- First in class
- No
- Orphan designation
- No
Mechanisms of action
- Mechanism
- Tetanus toxoid vaccine antigen
- Action type
- VACCINE_ANTIGEN
- Target
- Tetanus toxoid
- Condition
- Leukemia, Lymphocytic, Chronic, B-Cell
- Highest recorded phase
- 2
- Condition identifier
- EFO:0000095
- Subject identifier
- D015451
- Condition
- Astrocytoma
- Highest recorded phase
- 2
- Condition identifier
- EFO:0000272
- Subject identifier
- D001254
- Condition
- Melanoma
- Highest recorded phase
- 1
- Condition identifier
- EFO:0000389
- Subject identifier
- D008545
- Condition
- Infections
- Highest recorded phase
- 3
- Condition identifier
- EFO:0000544
- Subject identifier
- D007239
- Condition
- Neoplasms
- Highest recorded phase
- 1
- Condition identifier
- EFO:0000616
- Subject identifier
- D009369
- Condition
- Oligodendroglioma
- Highest recorded phase
- 2
- Condition identifier
- EFO:0000632
- Subject identifier
- D009837
- Condition
- Arthritis, Rheumatoid
- Highest recorded phase
- 2
- Condition identifier
- EFO:0000685
- Subject identifier
- D001172
- Condition
- HIV Infections
- Highest recorded phase
- 2
- Condition identifier
- EFO:0000764
- Subject identifier
- D015658
- Condition
- Multiple Myeloma
- Highest recorded phase
- 2
- Condition identifier
- EFO:0001378
- Subject identifier
- D009101
- Condition
- Pneumonia
- Highest recorded phase
- 3
- Condition identifier
- EFO:0003106
- Subject identifier
- D011014
- Condition
- Severe Dengue
- Highest recorded phase
- 3
- Condition identifier
- EFO:0004227
- Subject identifier
- D019595
- Condition
- Meningococcal Infections
- Highest recorded phase
- 3
- Condition identifier
- EFO:0004249
- Subject identifier
- D008589
- Condition
- Vaccination
- Highest recorded phase
- 4
- Condition identifier
- EFO:0004292
- Subject identifier
- D014611
- Condition
- Dengue
- Highest recorded phase
- 3
- Condition identifier
- EFO:0005547
- Subject identifier
- D003715
- Condition
- Tetanus
- Highest recorded phase
- 4
- Condition identifier
- EFO:0005593
- Subject identifier
- D013742
- Condition
- Typhoid Fever
- Highest recorded phase
- 1
- Condition identifier
- EFO:0006789
- Subject identifier
- D014435
- Condition
- Head and Neck Neoplasms
- Highest recorded phase
- 1
- Condition identifier
- EFO:0006859
- Subject identifier
- D006258
- Condition
- Paraganglioma
- Highest recorded phase
- 2
- Condition identifier
- EFO:1000453
- Subject identifier
- D010235
- Condition
- Meningitis, Meningococcal
- Highest recorded phase
- 3
- Condition identifier
- EFO:1001040
- Subject identifier
- D008585
- Condition
- Peritoneal Neoplasms
- Highest recorded phase
- 2
- Condition identifier
- MONDO:0002087
- Subject identifier
- D010534
- Condition
- Fallopian Tube Neoplasms
- Highest recorded phase
- 2
- Condition identifier
- MONDO:0002158
- Subject identifier
- D005185
- Condition
- Alzheimer Disease
- Highest recorded phase
- 1
- Condition identifier
- MONDO:0004975
- Subject identifier
- D000544
- Condition
- Multiple Sclerosis
- Highest recorded phase
- 3
- Condition identifier
- MONDO:0005301
- Subject identifier
- D009103
- Condition
- Colorectal Neoplasms
- Highest recorded phase
- 2
- Condition identifier
- MONDO:0005575
- Subject identifier
- D015179
- Condition
- Ovarian Neoplasms
- Highest recorded phase
- 2
- Condition identifier
- MONDO:0008170
- Subject identifier
- D010051
And 1 more, listed on the interactive page.
- Condition identifier
- EFO_0000272
- Condition identifier
- EFO_0000544
- Highest recorded phase
- 3
- Condition identifier
- EFO_0000616
- Highest recorded phase
- 1
- Condition identifier
- EFO_0000632
- Condition identifier
- EFO_0000650
- Condition identifier
- EFO_0000685
- Highest recorded phase
- 2
- Condition identifier
- EFO_0000764
- Highest recorded phase
- 2
- Condition identifier
- EFO_0001378
- Highest recorded phase
- 2
- Condition identifier
- EFO_0003106
- Highest recorded phase
- 3
- Condition identifier
- EFO_0004197
- Condition identifier
- EFO_0004227
- Highest recorded phase
- 2
- Condition identifier
- EFO_0004249
- Highest recorded phase
- 3
- Condition identifier
- EFO_0005549
- Condition identifier
- EFO_0005593
- Condition identifier
- EFO_0006789
- Condition identifier
- EFO_0006859
- Highest recorded phase
- 1
- Condition identifier
- EFO_0007450
- Condition identifier
- EFO_1000453
- Condition identifier
- EFO_1000874
- Condition identifier
- EFO_1001040
- Highest recorded phase
- 3
- Condition identifier
- MONDO_0004948
- Highest recorded phase
- 2
- Condition identifier
- MONDO_0004975
- Condition identifier
- MONDO_0004992
- Condition identifier
- MONDO_0005008
- Highest recorded phase
- 2
- Condition identifier
- MONDO_0005077
- Highest recorded phase
- 4
And 19 more, listed on the interactive page.
- Event
- drug hypersensitivity
- Reports
- 75
- Reporting signal score
- 220.98
- Event
- normal newborn
- Reports
- 3
- Reporting signal score
- 9.04551
- Event
- pertussis
- Reports
- 2
- Reporting signal score
- 9.2501
- Event
- renal aplasia
- Reports
- 2
- Reporting signal score
- 9.43044
- Event
- stevens-johnson syndrome
- Reports
- 4
- Reporting signal score
- 7.66423
- Event
- vaccination failure
- Reports
- 2
- Reporting signal score
- 9.5875
- Event
- wrong product administered
- Reports
- 5
- Reporting signal score
- 20.8236
- NCT00008866
- NCT02109354
- NCT00027833
- NCT01064375
- NCT00091273
- NCT00373217
- NCT00118274
- NCT00118313
- NCT00161928
- NCT02752906
- NCT02842853
- NCT02842866
- NCT02955797
- NCT00282308
- NCT00404339
- NCT00639639
- NCT00993447
- NCT01187433
- NCT02992418
- NCT01125527
- NCT01154088
- NCT03630705
- NCT03632720
- NCT03673462
- NCT03691610
And 15 more, listed on the interactive page.
- Dose
- 0.5mL
- Route
- Intramuscular
- How often
- At 2, 4, 6 and 15-18 months of age
- Discard unused portion
- Immediately after reconstitution
- Use immediately after reconstitution
- Prodrug
- No
- Chirality
- Single enantiomer
- Inorganic
- No
- Natural product
- No
Related records
Trials (71)
- A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever
- A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328
- Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td
- Characterisation of Human B Cell Maturation in Response to Vaccination
- Clinical Trial of the 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid)
- Comparative Study of Two Tetanus Toxoid Vaccination Strategies: Cold Chain Versus Controlled Temperature Chain
- Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study
- CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant
- Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma
- DC Migration Study for Newly-Diagnosed GBM
- DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
- Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine
- Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)
- Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy
- Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV
- Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation
- Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial
- Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Immunogenicity and Reactogenicity Study of BoostrixTM (dTpa) and Boostrix-IPV (dTpa-IPV)
- Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine
Approved for (1)
In development for (23)
- Alzheimer disease Phase 1
- Astrocytoma (excluding glioblastoma) Phase 2
- B-cell chronic lymphocytic leukemia Phase 2
- Colorectal cancer Phase 2
- COVID-19 Phase 3
- Cutaneous melanoma Phase 1
- Dengue disease Phase 3
- Dengue hemorrhagic fever Phase 3
- Fallopian tube cancer Phase 2
- Head and neck cancer Phase 1
- HIV infectious disease Phase 2
- Meningococcal infection Phase 3
- Meningococcal meningitis Phase 3
- Multiple sclerosis Phase 3
- Neoplasm Phase 1
- Oligodendroglioma Phase 2
- Ovarian cancer Phase 2
- Paraganglioma Phase 2
- Peritoneum cancer Phase 2
- Plasma cell myeloma Phase 2
Other linked conditions (5)
- Clostridium infectious disease
- Diphtheria
- Hepatitis B virus infection
- Pertussis
- Poliomyelitis